The Mammalian Cell Culture Technology laboratory is being developed at Department of BSE, NSUT, for generation of recombinant therapeutics, especially bispecific antibodies using mammalian expression vectors, with a feasibility of switchable heavy and light chain variable regions. Expression strategies being designed will generate novel combinations of bispecific antibodies targeting various cancers, autoimmune diseases, and inflammatory disorders.